Aggregation and the Intrinsic Structural Disorder of Dipeptide Repeat Peptides of C9orf72-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Characterized by NMR.
Aggregation and the Intrinsic Structural Disorder of Dipeptide Repeat Peptides of C9orf72-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Characterized by NMR.
复制标题
NMR 表征的 C9orf72 相关肌萎缩侧索硬化症和额颞叶痴呆的二肽重复肽的聚集和内在结构紊乱。
DOI:
10.1021/acs.jpcb.1c08149
复制
发表时间:
2021
期刊:
影响因子:
--
通讯作者:
Ramamoorthy,Ayyalusamy
中科院分区:
文献类型:
--
作者:
Krishnarjuna,Bankala;Ivanova,MagdalenaI;Ramamoorthy,Ayyalusamy
Dipeptide repeats (DPRs) are known to play important roles in C9ORF72-related amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Studies on DPRs have reported on the kinetics of aggregation, toxicity, and low-resolution morphology of the aggregates of these peptides. While the dipeptide hexa-repeats of Gly-Pro [(GP)6] have been shown to be nonaggregating, Gly-Ala [(GA)6] and Gly-Arg [(GR)6] exhibited the formation of neurotoxic aggregates. However, structural studies of these DPRs have been elusive. In this study, we explored the feasibility of a high-resolution monitoring of a real-time aggregation of these peptides in a solution by using NMR experiments. Although (GP)6is disordered and nonaggregating, the existence ofcisandtransconformations was observed from NMR spectra. It was remarkable that the (GR)6exhibited the formation of multiple conformations, whereas the hydrophobic and low-soluble (GA)6aggregated fast in a temperature-dependent manner. These results demonstrate the feasibility of monitoring the minor conformational changes from highly disordered peptides, aggregation kinetics, and the formation of small molecular weight aggregates by solution NMR experiments. The ability to detectcisandtranslocal isomerizations in (GP)6is noteworthy and could be valuable to study intrinsically disordered proteins/peptides by NMR. The early detection of minor conformational changes could be valuable in better understanding the mechanistic insights into the formation of toxic intermediates and the development of approaches to inhibit them and, potentially, aid in the development of compounds to treat the devastating C9ORF72-related ALS and FTD diseases.